Hanmi Pharm Co (XKRX:128940) Debt-to-Asset : 0.26 (As of Sep. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Hanmi Pharm Co Debt-to-Asset?

Hanmi Pharm Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₩405,563 Mil. Hanmi Pharm Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₩99,141 Mil. Hanmi Pharm Co's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2024 was ₩1,971,126 Mil. Hanmi Pharm Co's debt to asset for the quarter that ended in Sep. 2024 was 0.26.

Hanmi Pharm Co Debt-to-Asset Historical Data

The historical data trend for Hanmi Pharm Co's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hanmi Pharm Co Debt-to-Asset Chart

Hanmi Pharm Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

Get a 7-Day Free Trial

0.45

0.43

0.39

0.35

0.30

Hanmi Pharm Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Asset	Get a 7-Day Free Trial															0.30	0.30	0.29	0.26	0.26

Competitive Comparison of Hanmi Pharm Co's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Hanmi Pharm Co's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hanmi Pharm Co's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hanmi Pharm Co's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Hanmi Pharm Co's Debt-to-Asset falls into.

Hanmi Pharm Co Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Hanmi Pharm Co's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(483775.431	+	89091.835)	/	1898668.376
	=	0.30

Hanmi Pharm Co's Debt-to-Asset for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(405562.892	+	99140.541)	/	1971126.476
	=	0.26

Hanmi Pharm Co (XKRX:128940) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Hanmi Pharm Co Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Hanmi Pharm Co's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Hanmi Pharm Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hanmi Pharm Co Ltd (XKRX:128940) » Definitions » Debt-to-Asset

Traded in Other Exchanges

N/A

Address

45 Bangi-dong, Songpa, Seoul, Gyeonggi, KOR, 138-724

Website

http://www.hanmi.co.kr

Hanmi Pharm Co Ltd is a Korea-based company, engaged in manufacturing and marketing of medicines, medical supplies and raw materials for medicines. The company makes strenuous and enthusiastic efforts to develop treatments for diabetes, obesity, cancer, autoimmune and rare disease to keep everyone's health and improve their quality of life. The group distributes its products within Korean market and to overseas markets.

Hanmi Pharm Co Headlines

No Headlines